Growth Metrics

Immuron (IMRN) Receivables - Net (2016 - 2025)

Immuron's quarterly Receivables - Net came in at $18883.7 in Q3 2025, up 36.09% year-on-year from $13875.7 in Q3 2024, and down 98.47% quarter-over-quarter from $1.2 million in Q2 2025.

Immuron has reported Receivables - Net for 10 years, with the latest figure at $18883.7 in Q3 2025.

  • For the quarter ending Q3 2025, Receivables - Net rose 36.09% year-over-year to $18883.7; the trailing twelve-month figure through Sep 2025 stood at $18883.7 (up 36.09% YoY), and the FY2025 full-year result was $18883.7, up 36.09% from the prior year.
  • Receivables - Net for Q3 2025 stood at $18883.7, down from $1.2 million in the prior quarter.
  • The five-year high for Receivables - Net was $1.5 million in Q4 2024, with the low at $3347.1 in Q2 2021.
  • Average Receivables - Net over 5 years is $364950.0, with a median of $137606.6 recorded in 2021.
  • Year-over-year, Receivables - Net tumbled 99.16% in 2023 and jumped 40150.71% in 2024.
  • Tracing IMRN's Receivables - Net over 5 years: stood at $243834.3 in 2021, then surged by 78.62% to $435537.1 in 2022, then plunged by 99.16% to $3641.5 in 2023, then jumped by 40150.71% to $1.5 million in 2024, then plunged by 98.71% to $18883.7 in 2025.
  • The last three Receivables - Net figures came in at $18883.7 (Q3 2025), $1.2 million (Q2 2025), and $1.5 million (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Immuron 1.27 Bn 1.27 Bn -

Historic Data

Download Data 🔒
DateValue
Sep 2, 2025 18,883.70
Sep 2, 2025 18,883.70
Jun 30, 2025 1.23 Mn
Jun 30, 2025 1.23 Mn
Dec 31, 2024 1.47 Mn
Dec 31, 2024 1.47 Mn
Sep 9, 2024 13,875.73
Sep 9, 2024 13,875.73
Jun 30, 2024 914,444.58
Jun 30, 2024 914,444.58
Dec 31, 2023 3,641.52
Dec 31, 2023 3,641.52
Sep 28, 2023 273,610.37
Sep 28, 2023 273,610.37
Aug 30, 2023 4,174.20
Aug 30, 2023 4,174.20
Jun 30, 2023 31,378.85
Jun 30, 2023 31,378.85
Dec 31, 2022 435,537.13
Dec 31, 2022 435,537.13
Aug 31, 2022 460,993.04
Aug 31, 2022 460,993.04
Jun 30, 2022 6,628.96
Jun 30, 2022 6,628.96
Dec 31, 2021 243,834.30
Dec 31, 2021 243,834.30
Jun 30, 2021 3,347.07
Jun 30, 2021 3,347.07
Dec 31, 2020 949.51
Dec 31, 2020 949.51
Sep 1, 2020 154,904.00
Sep 1, 2020 154,904.00
Jun 30, 2020 214,774.13
Jun 30, 2020 214,774.13
Dec 31, 2019 3,276.89
Dec 31, 2019 3,276.89
Jun 30, 2019 233,237.65
Jun 30, 2019 233,237.65
Dec 31, 2018 1.68 Mn
Dec 31, 2018 1.68 Mn
Sep 27, 2018 1.23 Mn
Sep 27, 2018 1.23 Mn
Aug 30, 2018 1.68 Mn
Aug 30, 2018 1.68 Mn
Jun 30, 2018 1.27 Mn
Jun 30, 2018 1.27 Mn
Dec 31, 2017 1.38 Mn
Dec 31, 2017 1.38 Mn
Sep 28, 2017 1.39 Mn
Sep 28, 2017 1.39 Mn
Aug 31, 2017 1.77 Mn
Aug 31, 2017 1.77 Mn
Jun 30, 2017 202,920.69
Jun 30, 2017 202,920.69
Dec 31, 2016 3.31 Mn
Dec 31, 2016 3.31 Mn